Clinical Trial Update: Treatment of Autoimmune Thrombocytopenia (AITP) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating treatment for autoimmune thrombocytopenia has completed enrollment. The study also relates to autoimmune conditions such as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Autoimmune Thrombocytopenia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Autoimmune Disease, Autoimmune Hemolytic Anemia | Phase 1 | Status: COMPLETED